Comprehensive histone epigenetics: A mass spectrometry based screening assay to measure epigenetic toxicity.
MethodsX
; 7: 101055, 2020.
Article
em En
| MEDLINE
| ID: mdl-32995308
AUC, area under the curve; DDA, data-dependent acquisition; DIA, data-independent acquisition; DTT, dithiothreitol; Drug safety; FA, formic acid; FDR, false discovery rate; GABA, gamma-aminobutyric acid; GRX, gingisrex; HAT, histone acetyltransferase; HDACi, histone deacetylase inhibitor; HLB, hypotonic lysis buffer; HPLC, high-performance liquid chromatography; Histone post-translational modifications; K, Lysine; LC-MS/MS; M, Methionine; MS, Mass spectrometry; MS/MS, tandem mass spectrometry; N, asparagine; PBS, phosphate buffered saline; Pharmacoepigenetics; Proteomics; Q, glutamine; R, arginine; RA, relative abundance; RP, reversed phase; RT, room temperature; S, serine; SWATH, sequential window acquisition of all theoretical fragment ion spectra; T, threonine; TEAB, triethylammonium bicarbonate; Toxicoepigenetics; VPA, valproic acid; Y, tyrosine; hESC, human embryonic stem cell; hPTM, histone post-translational modification
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Diagnostic_studies
/
Prognostic_studies
/
Screening_studies
Idioma:
En
Revista:
MethodsX
Ano de publicação:
2020
Tipo de documento:
Article